Global Distribution of Tropical Diseases

Communities of practice

TropIKA.net Partnerships


South-South Initiative for Tropical Diseases Research
Initiative to Strengthen Health Research Capacity in Africa (ISHReCA)
Malaria Eradication Research Agenda (malERA)
Research Partnerships for Neglected Diseases of Poverty

Content Type: Review Articles

Disease: Leishmaniasis

Review Articles Results  Click for RSS

Registered users may save selected Research Articles, Review Articles and Editorials to the My Articles area of My Virtual Journals.

Displaying results 1-10 of 10

Sort by: | Date

Select All

2 Jun 2010

Do the poor benefit from infectious disease programmes?

When interventions are planned, insufficient thought is given as to whether the poorest and most vulnerable members of society will benefit, according to the findings of a new review of the evidence. The reviewers call for more research to assess which infectious disease programmes benefit the poor and to identify the mechanisms that determine “pro-poor effectiveness”.
Source: TropIKA.net Journal
Read... | PDF

31 May 2010

Treating patients with visceral leishmaniasis in the Indian subcontinent: the evidence from clinical trials

A review of trials concludes that three drugs are of overall benefit, despite their side effects. Most research has been conducted in India; more must be done to confirm which drugs work best in Bangladesh and Nepal and to bring effective treatment to patients in all three countries.
Source: TropIKA.net Journal
Read... | PDF

9 Mar 2010

Vector-borne diseases: what will be the impact of climate and other environmental changes?

A review concludes that we do not know enough about the ecology of diseases such as malaria and dengue to be able to make accurate predictions. Nevertheless, appropriate action can be taken now to reduce their impact.
Source: Journal of Experimental Biology
Read... | PDF

15 Sep 2009

Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden

A review demonstrates the high burden due to NTDs in Africa. The authors call for this category of diseases to be accorded a higher priority.
Source: PLoS Neglected Tropical Diseases
Read... | PDF

14 Nov 2008

Complexities of assessing the disease burden attributable to leishmaniasis

Assessing the burden of disease due to leishmaniasis is problematic. The authors of this review suggest how it may be more accurately estimated and how improvements can be made in monitoring the effectiveness of control programmes.
Source: PLoS Neglected Tropical Diseases
Read... | PDF

10 Jul 2008

Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – case report and systematic review

The association between these two conditions may be often overlooked.
Source: Journal of Infection
Read...

11 Jun 2008

Modulation of dendritic cell function by Leishmania parasites

Current data regarding the complex interactions between Leishmania parasites and dendritic cells are discussed.
Source: Journal of Immunology
Read...

17 Jan 2008

Climate Variability And Visceral Leishmaniasis In Europe1

A three-year pan-European project entitled Climate change and adaptation strategies for human health (cCASHh), funded under the European Union thematic programme on Energy, Environment and Sustainable Development (EESD-1999), began in 2000.
Source: WHO/TDR
Read... | PDF

1 Nov 2007

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Early and accurate diagnosis and treatment remain key components of VL control.
Source: Nature Reviews Microbiology
Read... | PDF

1 Nov 2007

The Importance Of Risk Factors In The Control Of Leishmaniasis

The leishmaniases are vector-borne diseases, and are highly complex: they are usually zoonotic; a large number of Leishmania species infect humans; the biological cycles and epidemiological interrelationships between vector, reservoir, humans, climate and ecology are highly variable; they have multifaceted clinical manifestations (due to the genetic heterogenicity of both parasite and humans) and outcomes (which vary from spontaneously cured to not curable) as a consequence of disease.
Source: WHO/TDR
Read... | PDF

Sign in

Email

Password

Register for free
Forgot your password?

Is your organisation working against the infectious diseases of poverty?

Tell TropIKA.net